IGFBP7 and metabolic syndrome: In the overall study populations, patients with metabolic syndrome showed significant increase in the IGFBP-7/IGF-1 ratio compared to patients without metabolic syndrome (0.53 [0.41-0.74] vs. 0.47 [0.36-0.59], respectively, p =0.002).